Purdue Pharma

From left: VT Attorney General T.J. Donovan, Kate Van Hayes from Senator Bernie Sanders Office, Assistant Attorney General Jill Abrams, Howard Center Executive Director Bob Bick
Pat Bradley/WAMC

The Vermont Attorney General is going back to court over the opioid crisis. T.J. Donovan has filed a third lawsuit against manufacturers or distributors of the drugs that the office claims had key roles in creating the opioid epidemic in the state.

Letitia James
Facebook: New York State Attorney General

New York Attorney General Letitia James has filed what the Democrat calls the country’s most extensive lawsuit against pharmaceutical manufacturers and distributors for their alleged role in the opioid epidemic.

Vermont Attorney General T.J. Donovan announces lawsuit against drug distributors
Pat Bradley/WAMC

Last September, Vermont Attorney General T.J. Donovan stood in front of the Chittenden County Superior Court to announce that the state was suing Purdue Pharma, the manufacturer of Oxycontin and other opioids. Today, he was back to announce new lawsuits against two drug distributors.

In September 2018 Vermont Attorney General T.J. Donovan announced a lawsuit against Purdue Pharma
Pat Bradley/WAMC

A Vermont court has denied an opioid manufacturer’s motion to dismiss claims brought by the state against the company.

In September 2018 Vermont Attorney General T.J. Donovan announced a lawsuit against Purdue Pharma
Pat Bradley/WAMC

Vermont’s Attorney General is suing Purdue Pharma, saying the manufacturer of Oxycontin has driven the opioid addiction crisis. T.J. Donovan says the billion dollar industry must account for misleading marketing.

In September 2018 Vermont Attorney General T.J. Donovan announced a lawsuit against Purdue Pharma
Pat Bradley/WAMC

Vermont is suing a major drug company over its prescription opioid marketing practices that the attorney general says led to the drug crisis in Vermont and around the country.

Flickr

Nevada and five other states are filing new lawsuits accusing a Connecticut-based pharmaceutical company of using deceptive marketing to boost drug sales that fueled opioid overdose deaths.